Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
A Study of Therapeutic Iobenguane (131-I) for Relapsed, High-Risk Neuroblastoma Subjects (OPTIMUM)
Complete Title: SC-4009: A PHASE II SINGLE-ARM STUDY OF THERAPEUTIC IOBENGUANE (131I) FOR HIGH-RISK NEUROBLASTOMA SUBJECTS AT THE TIME OF FIRST RELAPSE
Trial Phase: II
Investigator: Julie Park
The purpose of this study is to evaluate the efficacy and safety of 131I-MIBG in patients with neuroblastoma, who relapsed.
Keywords:
- Neuroblastoma
- Neoplasms
- Neuroectodermal Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
Adult
Pediatric
II
Julie Park
SC-4009
NCT03561259
SC-4009: A PHASE II SINGLE-ARM STUDY OF THERAPEUTIC IOBENGUANE (131I) FOR HIGH-RISK NEUROBLASTOMA SUBJECTS AT THE TIME OF FIRST RELAPSE
Neuroblastoma
Neoplasms
Neuroectodermal Tumors